Ledger.Open graph →
SEC Form D · filed March 19, 2020

Silverback Therapeutics, Inc

Offering
$78.7M
Sold
$31.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Thilo Schroeder · Seattle, WADirectorSaqib Islam · Seattle, WADirectorPeter Thompson · Seattle, WAExec · DirectorRobert Hershberg · Seattle, WADirectorJonathan Root · Maple Grove, MNDirectorPeter Thompson · New York, NYExec · DirectorRobert Hershberg · Seattle, WADirectorThilo Schroeder · Seattle, WADirectorJonathan Root · San Francisco, CADirectorSaqib Islam · Philadelphia, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗